European Union Registry in Paediatric Chronic Kidney Disease Patients Looking at Safety and Usage Patterns of Darbepoetin Alfa

Extension From Weekly to Once Every Other Week Darbepoetin Alfa Administration in Subjects With Chronic Kidney Disease Receiving Dialysis

NCT00436995 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of Monthly Darbepoetin Alfa Dosing for Correction of Anemia in Non-dialysis Chronic Kidney Disease

NCT00925587 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Safety and Efficacy of Oral Vadadustat in Pediatric Participants With Anemia of Chronic Kidney Disease

NCT05082571 ·Status: WITHDRAWN ·Phase: PHASE3

Darbepoetin Alfa Treatment of Anemia in Hemodialysis Subjects

NCT00119587 ·Status: COMPLETED ·Phase: PHASE3

Phase 2 Study of Darbepoetin Alfa Extended Dosing

NCT00527215 ·Status: COMPLETED ·Phase: PHASE2

Treatment for Subjects With Chronic Kidney Disease (CKD) Not Receiving Dialysis

NCT00111098 ·Status: COMPLETED ·Phase: PHASE3

An Evaluation of Aranesp® in Subjects With Anaemic Chronic Kidney Disease (CKD)

NCT00124098 ·Status: COMPLETED ·Phase: PHASE3

Study for Subjects With Chronic Kidney Disease(CKD) Not Receiving Dialysis

NCT00112008 ·Status: COMPLETED ·Phase: PHASE3

Efficacy Study: Darbepoetin Alfa for the Treatment of Anemia in Patients With Chronic Kidney Disease

NCT00121602 ·Status: COMPLETED ·Phase: PHASE3

NESP Pediatric Study

NCT00527137 ·Status: COMPLETED ·Phase: PHASE3

Comparison of Darbepoetin Alpha and Recombinant Human Erythropoietin for Treatment of Anemia in Children With Chronic Kidney Disease

NCT04959578 ·Status: COMPLETED ·Phase: PHASE4

Study to Evaluate the Safety and Efficacy of Oral Vadadustat in Pediatric Participants With Anemia of Chronic Kidney Disease Naive to Erythropoiesis-Stimulating Agents

NCT05082584 ·Status: WITHDRAWN ·Phase: PHASE3

Study of the Efficacy of Darbepoetin Alfa in the Treatment of Renal Anemia

NCT00563446 ·Status: COMPLETED ·Phase: NA

Erythropoiesis Stimulating Agents for Anemia Management in Egyptian Hemodialysis Patients

NCT05699109 ·Status: COMPLETED

Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease

NCT01652872 ·Status: COMPLETED ·Phase: PHASE3

Effects Of Darbepoetin On Vascular Repair Mechanisms In Kidney Disease The DARBEPC Study

NCT00396123 ·Status: COMPLETED

A Study of Intermittent Oral Dosing of ASP1517 in Hemodialysis Chronic Kidney Disease Patients With Anemia

NCT02952092 ·Status: COMPLETED ·Phase: PHASE3

Renal Anemia Refractory to Erythropoietin

NCT03480178 ·Status: UNKNOWN

The Effect of Salicylate on Platelet Function in CKD (Chronic Kidney Disease) Patients Treated With Aranesp

NCT04330729 ·Status: RECRUITING ·Phase: NA

Evaluation of Two Epoetin Alfa Dosing Strategies in Subjects With Chronic Kidney Disease Receiving Hemodialysis

NCT02253654 ·Status: COMPLETED ·Phase: PHASE4

Epoetin Alfa (EPO) in Subjects With Chronic Kidney Disease (CKD)

NCT00156962 ·Status: TERMINATED ·Phase: PHASE3

A Dose Conversion Study of Epoetin Alfa in Subjects With the Anemia of Chronic Kidney Disease.

NCT00495365 ·Status: TERMINATED ·Phase: PHASE4

Treatment for Subjects With Chronic Kidney Disease Receiving Haemodialysis

NCT00116701 ·Status: COMPLETED ·Phase: PHASE3

A Phase III Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)

NCT02912494 ·Status: COMPLETED ·Phase: PHASE3

Cost Comparison Study of Darbepoetin Versus Epoetin Therapy to Treat Anemia in Hemodialysis Patients

NCT02817555 ·Status: COMPLETED ·Phase: PHASE4